Adrenaline devices dispensed for use in children and young people aged 0–17 years in the UK
| Generic name | % (of total)a | Age ≤5 years % (of total)a | Age ≥6 years % (of total)a |
|---|---|---|---|
| Junior devices (dispense 150 µg) | |||
| Adrenaline (base) 150 µg/0.15 ml (1 in 1000) solution for injection pre-filled disposable devices | 2.48 | 3.95 | 1.91 |
| Adrenaline (base) 150 µg/0.3 ml (1 in 2000) solution for injection pre-filled disposable devices | 64.56 | 95.34 | 52.54 |
| Adult devices (dispense 300 µg) | |||
| Adrenaline (base) 300 µg/0.3 ml (1 in 1000) solution for injection pre-filled disposable devices | 32.93 | 0.7 | 45.49 |
| Higher dosage devices (dispense 500 µg) | |||
| Adrenaline (base) 500 µg/0.3 ml (1 in 600) solution for injection pre-filled disposable devices | 0.03 | 0 | 0.04 |
| Adrenaline inhalers | |||
| Adrenaline acid tartrate 280 µg/inhalation inhaler | 0.01 | 0.01 | 0.01 |
↵a There are no figures presented for totals as these are cumulative over 12 years.